Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiocyanate oxidation is primarily catalyzed in biology by **thiocyanate dehydrogenase (TcDH)**, a copper-containing oxidoreductase enzyme. This enzyme mediates the two-electron oxidation of thiocyanate (SCN⁻) to cyanate and elemental sulfur, transferring electrons to external acceptors such as cytochromes[2][4][8]. In mammals, peroxidases such as lactoperoxidase and myeloperoxidase catalyze oxidation of SCN⁻ to hypothiocyanite (OSCN⁻) using hydrogen peroxide, yielding antimicrobial species critical for innate immunity[6][7][10]. Thiocyanate oxidation also occurs chemically, with various oxidants (peroxomonosulfate, iodate) yielding different products under specific conditions[3][5][9][10]. TcDH genes are present in bacteria that use thiocyanate as an energy source, especially *Thioalkalivibrio* genus, and are important for both natural and biotechnological applications such as industrial wastewater treatment[4][2]. OSCN⁻ generation is clinically relevant due to its high antimicrobial efficacy and minimal host toxicity, making modulation of thiocyanate oxidation a promising therapeutic strategy[6][7]. If the intention was to identify a discrete molecular target (enzyme, receptor, etc.), the correct entity is **"Thiocyanate dehydrogenase (TcDH)"** and not the general reaction "Thiocyanate oxidation". Using the process name as a target is incorrect; all information above refers to the enzyme TcDH or the peroxidase enzymes that mediate thiocyanate oxidation[2][4][6][8][10].
Catalysis of SCN⁻ oxidation to cyanate, hypothiocyanite, elemental sulfur, or sulfate depending on the enzyme and cofactor/oxidant Generation of antimicrobial OSCN⁻ through peroxidase-mediated oxidation in secretory mucosa
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiocyanate dehydrogenase (TcDH).